The recognition was presented at the company's offices in Alcobendas, noted for its business strength and specialization in the pharmaceutical sector. Alcobendas already has six companies distinguished with this seal, a figure that is soon to increase.
Founded in March 2022, Capital Farma focuses on the development and distribution of high-quality pharmaceutical active ingredients (APIs). In five years, it has expanded its commercial activity to 20 countries and quintupled its team from four to 22 professionals, with offices in India and South America.
Óscar Núñez Insausti, CEO of the company, received the award from Rocío García Alcántara, Mayoress of Alcobendas, and Elena Mantilla, Director General of Madrid Excelente. The Mayoress highlighted the importance of institutional collaboration in strengthening Madrid's biopharmaceutical ecosystem, which comprises around 400 companies in the sector.
Capital Farma's eight-year strategic plan includes consolidating distribution, developing proprietary molecules, and transitioning to industrial manufacturing in Europe. 50% of its profits will be allocated to new molecular developments in Europe, aiming to reduce Asian dependency.
The company is working on developing molecules that are no longer produced in Europe, such as treatments for burns and Alzheimer's, contributing to the recovery of industrial capabilities and supply diversification.
Madrid Excelente emphasizes Capital Farma's incorporation as a young company with international presence and a clear investment strategy, reaffirming the Community of Madrid's commitment to quality in a sector vital for economic activity and innovation.
